Sterling Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.42M | Buy |
20,195
+3,017
| +18% | +$660K | 0.06% | 215 |
|
|
2025
Q1 | $3.85M | Sell |
17,178
-690
| -4% | -$154K | 0.06% | 217 |
|
|
2024
Q4 | $5.85M | Buy |
17,868
+473
| +3% | +$155K | 0.08% | 178 |
|
|
2024
Q3 | $5.22M | Buy |
+17,395
| New | +$5.22M | 0.07% | 209 |
|
|
2019
Q3 | $27.8M | Sell |
196,173
-25,500
| -12% | -$3.62M | 0.26% | 111 |
|
|
2019
Q2 | $27.7M | Hold |
221,673
| – | – | 0.27% | 109 |
|
|
2019
Q1 | $24.4M | Sell |
221,673
-50,000
| -18% | -$5.51M | 0.24% | 121 |
|
|
2018
Q4 | $26.6M | Sell |
271,673
-65,232
| -19% | -$6.39M | 0.29% | 108 |
|
|
2018
Q3 | $41.6M | Hold |
336,905
| – | – | 0.38% | 94 |
|
|
2018
Q2 | $33.5M | Hold |
336,905
| – | – | 0.31% | 96 |
|
|
2018
Q1 | $29.7M | Buy |
336,905
+39,424
| +13% | +$3.48M | 0.28% | 108 |
|
|
2017
Q4 | $29.4M | Sell |
297,481
-44,979
| -13% | -$4.44M | 0.27% | 102 |
|
|
2017
Q3 | $33M | Buy |
342,460
+15,160
| +5% | +$1.46M | 0.31% | 98 |
|
|
2017
Q2 | $30.9M | Sell |
327,300
-70,000
| -18% | -$6.62M | 0.3% | 98 |
|
|
2017
Q1 | $32.4M | Sell |
397,300
-654
| -0.2% | -$53.4K | 0.31% | 98 |
|
|
2016
Q4 | $33.8M | Sell |
397,954
-37,346
| -9% | -$3.17M | 0.3% | 96 |
|
|
2016
Q3 | $32.4M | Hold |
435,300
| – | – | 0.3% | 95 |
|
|
2016
Q2 | $33M | Sell |
435,300
-117,000
| -21% | -$8.88M | 0.3% | 98 |
|
|
2016
Q1 | $38.3M | Sell |
552,300
-96,000
| -15% | -$6.65M | 0.35% | 95 |
|
|
2015
Q4 | $39M | Hold |
648,300
| – | – | 0.35% | 97 |
|
|
2015
Q3 | $35.1M | Buy |
+648,300
| New | +$35.1M | 0.31% | 104 |
|